CSIMarket



Quest Diagnostics Inc  (DGX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

DGX's Income from Cont. Operations Growth by Quarter and Year

Quest Diagnostics Inc's Income from Cont. Operations results by quarter and year




DGX Income from Cont. Operations (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 413.00 609.00 265.00
III Quarter September - 527.00 591.00 226.00
II Quarter June - 650.00 193.00 219.00
I Quarter March 373.00 490.00 106.00 176.00
FY   373.00 2,080.00 1,499.00 886.00



DGX Income from Cont. Operations first quarter 2022 Y/Y Growth Comment
Quest Diagnostics Inc reported decline in Income from Cont. Operations in the first quarter 2022 by -23.88% to $ 373.00 millions, from the same quarter in 2021.
The contraction in the first quarter 2022 Quest Diagnostics Inc's Income from Cont. Operations compares unfavorably to the Company's average Income from Cont. Operations growth of 3.03%.

Among companies who have reported first quarter 2022 results in the Medical Laboratories industry only one Company has achieved higher year on year Income from Cont. Operations results in the first quarter 2022. While Quest Diagnostics Inc' s Income from Cont. Operations fall of -23.88% ranks overall at the positon no. 91 in the first quarter 2022.




DGX Income from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - -32.18 % 129.81 % 34.52 %
III Quarter September - -10.83 % 161.5 % -0.44 %
II Quarter June - 236.79 % -11.87 % -6.01 %
I Quarter March -23.88 % 362.26 % -39.77 % -6.88 %
FY   - 38.76 % 69.19 % 4.73 %

Financial Statements
Quest Diagnostics Inc's first quarter 2022 Income from Cont. Operations $ 373.00 millions DGX's Income Statement
Quest Diagnostics Inc's first quarter 2021 Income from Cont. Operations $ 490.00 millions Quarterly DGX's Income Statement
New: More DGX's historic Income from Cont. Operations Growth >>


DGX Income from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - -21.63 % 3.05 % 17.26 %
III Quarter September - -18.92 % 206.22 % 3.2 %
II Quarter June - 32.65 % 82.08 % 24.43 %
I Quarter March -9.69 % -19.54 % -60 % -10.66 %
FY (Year on Year)   - 38.76 % 69.19 % 4.73 %




Income from Cont. Operations first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #2
Healthcare Sector #4
Overall #91

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
46.2 % 3.03 % -33.42 %
(Sep 30 2020)   (Sep. 30, 2014)
Income from Cont. Operations first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #2
Healthcare Sector #4
Overall #91
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
46.2 % 3.03 % -33.42 %
(Sep 30 2020)   (Sep. 30, 2014)

Income from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Quest Diagnostics Inc's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
206.22 % 8.8 % -64.1 %
(Sep 30 2020)  


DGX's I. Quarter Q/Q Income from Cont. Operations Comment
In the I. Quarter 2022 Quest Diagnostics Inc disclosed drop in Income from Cont. Operations from the forth quarter by -9.69% to $ 373.00 millions, from $ 413.00 millions achived in the previous reporting period.

It's not important problem, as Quest Diagnostics Inc's Income from Cont. Operations frequently seem to plunge in the I. Quarter Molly O. Scott, Medical Laboratories industry veteran located in Boston told.

Within Medical Laboratories industry Quest Diagnostics Inc achieved highest sequential Income from Cont. Operations growth. While Quest Diagnostics Inc's Income from Cont. Operations growth quarter on quarter, overall rank is 59.


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #1
Healthcare Sector #3
Overall #59
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #1
Healthcare Sector #3
Overall #59
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
206.22 % 8.8 % -64.1 %
(Sep 30 2020)  


DGX's I. Quarter Q/Q Income from Cont. Operations Comment
In the I. Quarter 2022 Quest Diagnostics Inc reported drop in Income from Cont. Operations sequentially by -9.69% to $ 373.00 millions, from $ 413.00 millions released in the previous quarter.

As we look into current slump in the I. Quarter 2022, we suppose to presume, that usually I. Quarter performance occur weaker in contrast to the preciding period, Molly O. Scott, Medical Laboratories industry veteran located in Boston said.

Within Medical Laboratories industry Quest Diagnostics Inc achieved highest sequential Income from Cont. Operations growth. While Quest Diagnostics Inc's Income from Cont. Operations growth quarter on quarter, overall rank is 59.


Quest Diagnostics Inc's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Income from Cont. Operations 12 Months Ending $ 1,963.00 $ 2,080.00 $ 2,276.00 $ 2,340.00 $ 1,883.00
Y / Y Income from Cont. Operations Growth (TTM) 4.25 % 38.76 % 97.06 % 196.2 % 130.76 %
Year on Year Income from Cont. Operations Growth Overall Ranking # 71 # 975 # 482 # 20 # 22
Seqeuential Income from Cont. Operations Change (TTM) -5.63 % -8.61 % -2.74 % 24.27 % 25.62 %
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # 91 # 1834 # 1660 # 44 # 705




Cumulative Income from Cont. Operations growth Comment
With the quarterly Income from Cont. Operations reported in the Mar 31 2022 period, Quest Diagnostics Inc's cumulative twelve months Income from Cont. Operations were $ 1,963 millions, company would post below average annual Income from Cont. Operations growth of 25.62% year on year, if the fiscal year would end at Mar 31 2022.
A slow-down in the Quest Diagnostics Inc's Income from Cont. Operations growth from the 413% growth in Dec 31 2021. Comparing the results with it's peers in Medical Laboratories industry, Quest Diagnostics Inc's trailing twelve months Income from Cont. Operations growth, were the second highest.

Looking into Healthcare sector trailing twelve month Income from Cont. Operations increase, only one company had higher growth. While Total ranking has impoved so far to 71, from total ranking in previous quarter at 975.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
46.2 %
3.03 %
-33.42 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 2
Healthcare Sector # 2
Overall # 71

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
196.2 %
13.37 %
-35.86 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 4
S&P 500 # 91
Cumulative Income from Cont. Operations growth Comment
With the quarterly Income from Cont. Operations reported in the Mar 31 2022 period, Quest Diagnostics Inc's cumulative twelve months Income from Cont. Operations were $ 1,963 millions, company would post below average annual Income from Cont. Operations growth of -35.86% year on year, if the fiscal year would end at Mar 31 2022.
A slow-down in the Quest Diagnostics Inc's Income from Cont. Operations growth from the 413% growth in Dec 31 2021. Comparing the results with it's peers in Medical Laboratories industry, Quest Diagnostics Inc's trailing twelve months Income from Cont. Operations growth, were the second highest.

Looking into Healthcare sector trailing twelve month Income from Cont. Operations increase, only one company had higher growth. While Total ranking has impoved so far to 71, from total ranking in previous quarter at 975.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
46.2 %
3.03 %
-33.42 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 2
Healthcare Sector # 2
Overall # 71

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
196.2 %
13.37 %
-35.86 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 4
S&P 500 # 91




Other Income from Cont. Operations Growth
Medical Laboratories Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
DGX's Income from Cont. Operations Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for DGX's Competitors
Income from Cont. Operations Growth for Quest Diagnostics Inc's Suppliers
Income from Cont. Operations Growth for DGX's Customers

You may also want to know
DGX's Annual Growth Rates DGX's Profitability Ratios DGX's Asset Turnover Ratio DGX's Dividend Growth
DGX's Roe DGX's Valuation Ratios DGX's Financial Strength Ratios DGX's Dividend Payout Ratio
DGX's Roa DGX's Inventory Turnover Ratio DGX's Growth Rates DGX's Dividend Comparisons



Companies with similar Income from Cont. Operations drop for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Mar 31 2022
Chemed Corporation-1.88%$ -1.882 millions
Biomx Inc -2.77%$ -2.773 millions
Ironwood Pharmaceuticals inc -2.82%$ -2.818 millions
Corcept Therapeutics Inc-2.85%$ -2.847 millions
Msa Safety Inc-2.89%$ -2.891 millions
Merit Medical Systems Inc-3.77%$ -3.769 millions
Addus Homecare Corporation-4.77%$ -4.767 millions
Idexx Laboratories Inc-5.05%$ -5.054 millions
Hca Healthcare Inc -7.28%$ -7.278 millions
National Research Corporation-7.51%$ -7.506 millions
Amgen Inc -10.33%$ -10.328 millions
Organon and Co -11.90%$ -11.899 millions
Regeneron Pharmaceuticals Inc -12.71%$ -12.706 millions
Intuitive Surgical Inc -15.12%$ -15.119 millions
Apollo Medical Holdings Inc -16.50%$ -16.496 millions
Encompass Health Corporation-17.09%$ -17.093 millions
Molecular Templates Inc -19.30%$ -19.296 millions
Royalty Pharma Plc-19.43%$ -19.434 millions
Natus Medical Inc-20.58%$ -20.576 millions
Fulgent Genetics Inc -23.49%$ -23.486 millions
Quest Diagnostics Inc-23.88%$ -23.878 millions
Fonar Corporation-24.12%$ -24.122 millions
Hologic Inc-26.49%$ -26.488 millions
Integra Lifesciences Holdings Corp-27.52%$ -27.521 millions
Universal Health Services Inc -27.77%$ -27.765 millions
National Healthcare Corp-27.97%$ -27.966 millions
Incyte Corp-29.03%$ -29.033 millions
Davita Inc -29.44%$ -29.439 millions
Reynolds Consumer Products Inc -29.73%$ -29.730 millions
Semler Scientific inc -31.11%$ -31.105 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BZFD's Profile

Stock Price

BZFD's Financials

Business Description

Fundamentals

Charts & Quotes

BZFD's News

Suppliers

BZFD's Competitors

Customers & Markets

Economic Indicators

BZFD's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071